✦ LIBER ✦

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

✍ Scribed by Leone, JosÃ© Pablo; Leone, Julieta; Vallejo, Carlos Teodoro; PÃ©rez, Juan Eduardo; Romero, Alberto Omar; Machiavelli, Mario Raul; Romero AcuÃ±a, Luis; DomÃnguez, MarÃa Ester; Langui, Mario; Fasce, Hebe Margot; Leone, Bernardo Amadeo; Ortiz, Eduardo; Iturbe, JuliÃ¡n; Zwenger, Ariel Osvaldo

Book ID: 121455719
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 359 KB
Volume: 143
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2806-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fifteen-year median follow-up results af

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 325 KB

A phase III trial of taxotere and doxoru

A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis

✍ K. Bouzid; J. Vinholes; F. Salas; E. Mickiewicz; S. Valdivia; V. Ostapenko; E. B 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

Randomized phase III trial of adjuvant e

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

✍ Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Roc 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 485 KB

Final Results of a Randomized Phase III

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

✍ Therasse, P. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB

Trade-offs in quality of life and surviv

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

✍ Lee, Chee; Gebski, Val J; Coates, Alan S; Veillard, Anne-Sophie; Harvey, Vernon; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 243 KB